Clinical Trial Update: Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating belinostat in combination with azacitidine, gemcitabine, busulfan, and melphalan with autologous stem-cell transplantation for refr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Alkeran (melphalan)
• BELEODAQ (BELINOSTAT)
• Busulfex (busulfan)
• Gemzar (gemcitabine)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN